For more information or confidential assistance
Call 800-306-3180

Pradaxa vs Warfarin: FDA Weighs In

The Food and Drug Administration has published an editorial detailing the complications patients have encountered associated with the blood thinning medications Pradaxa and warfarin. Pradaxa is a relatively new medication that was marketed as a replacement to warfarin, which was the leading anticoagulant drug on... Read More

Centralization of Mirena Lawsuits Under Consideration

Centralization of Mirena lawsuits is currently under consideration, as more plaintiffs come forward with reports of serious injury connected to the contraceptive device. The U.S. Judicial Panel on Multidistrict Litigation (JMPL) is currently weighing a decision to coordinate claims involving Mirena side effects into a... Read More

FDA’s Pradaxa Study Criticized

The Food and Drug Administration recently released a report that showed that the bleeding risks of Pradaxa are comparable to the risks associated with a competing, older drug, known as warfarin. Many patients are skeptical of this report, as the Food and Drug Administration relied... Read More